Location History:
- San Diego, CA (US) (2006 - 2012)
- Ibaraki, JP (2013)
- Sapporo, JP (2014 - 2018)
- Osaka, JP (2014 - 2021)
Company Filing History:
Years Active: 2006-2021
Title: Yasunobu Tanaka: An Innovator in Therapeutic Agent Delivery
Introduction: Yasunobu Tanaka is a prolific inventor based in Osaka, Japan, recognized for his significant contributions to the field of pharmaceutical formulations and therapeutic agent delivery. With a remarkable portfolio of 22 patents, his work is geared towards enhancing drug delivery systems and improving the efficacy of treatment options available in modern medicine.
Latest Patents: Among his notable inventions, Tanaka's latest patents include compositions for cationic lipids designed for therapeutic agent delivery. This patent describes a sophisticated composition involving a compound with specific structural attributes, emphasizing the importance of various selected groups to achieve effective delivery mechanisms. Another key patent outlines compounds aimed at targeting drug delivery and enhancing siRNA activity. This innovation consists of a unique structure featuring a targeting molecule linked to a polyethylene glycol (PEG) or PEG-like molecule, ideal for focused therapeutic action on target cells.
Career Highlights: Yasunobu Tanaka's career is marked by his association with Nitto Denko Corporation, a leading company in the development of advanced materials and solutions. His work at the corporation reflects his commitment to pushing the boundaries of innovation in drug delivery technologies.
Collaborations: Throughout his career, Tanaka has had the opportunity to collaborate with esteemed professionals in his field, including Yoshiro Niitsu and Victor Knopov. These collaborations have undoubtedly enriched his research and have contributed to the successful development of his patented technologies.
Conclusion: Yasunobu Tanaka stands out as a trailblazer in the pharmaceutical industry, with patents that hold immense potential for transforming therapeutic treatments. His dedication to innovation and collaboration serves as an inspiration for future inventors and researchers in the domain of drug delivery and therapeutic agents.